Patient’s Adherence to Insulin Pen At prince Ali Bin Al Hussein Hospital in Jordan
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.6, No. 4)Publication Date: 2023-07-15
Authors : Ola Dmor; Amal Al Jariri Mostafa Qasem; Mohamma Al Jariri; Alaa Al Faraheed;
Page : 30-32
Keywords : ;
Abstract
Diabetes mellitus is an extended metabolic disorder and disease that has an important financial freight on the healthcare organization associated with intended and unintended medical costs, loss of effectiveness, and premature death unless controlled. Objectives: evaluating the adherence toward insulin therapy among patients with diabetes with insulin pen compared to old-style insulin treatment. Methods: The examination was conducted by a cross-sectional, and patients were recruited. The client adherence survey was achieved in an internal clinic of medicine by a clinical pharmacist and a nurse using a designed interview technique (face-to-face) where the affected role was asked questions, a questionnaire consisting of demographic statistics, nature of insulin applied, and inquiries concerning patient adherence to the use insulin pen regimen. Results were analyzed and evaluated by using the program SPSS version 21. Results: A high ratio of patients from the insulin pen users (87%) found that the method simple to use as compared to the conventional insulin. Conclusion: there is a general and very good impression that there is general education for diabetics, and that patients who use pre-filled pens and insulin pens are the ones who adhere well to their treatment and that they are less likely to have complications from low and high blood sugar
Other Latest Articles
- A Review Article on Oral Mucosal Drug Delivery System
- Increasing Knowledge of HIV/AIDS Among Adolescents Through Health Promotion
- A New Approach for Drug Delivery Schedules Using Chronopharmacology
- Malignant Varicella in an Immunocompetent Patient: A New Case Report
- Development and Validation of Tezacaftor and Ivacaftor in combined Pharmaceutical Dosage form by RP- UPLC
Last modified: 2023-07-12 20:01:00